Similar articles for PMID: 21419775

Year	Number of Results
1947	1
1952	1
1953	1
1955	1
1958	3
1959	1
1960	5
1961	2
1962	1
1964	2
1965	3
1966	4
1967	3
1968	2
1969	5
1970	4
1971	5
1972	2
1973	5
1974	3
1975	1
1976	1
1977	2
1978	1
1979	1
1980	4
1982	1
1990	1
1993	1
1995	1
1996	1
1997	1
1999	1
2006	2
2007	2
2008	4
2009	23
2010	31
2011	38
2012	9
2013	8
2014	2
2015	4
2016	3
2017	2
2018	1
2020	4
2021	1
2022	1
2023	1
2024	0

1

Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children.

Meier S, Bel M, L'huillier A, Crisinel PA, Combescure C, Kaiser L, Grillet S, Pósfay-Barbe K, Siegrist CA; H1N1 Epidemiology Study Group of Geneva. Meier S, et al. Vaccine. 2011 Apr 27;29(19):3548-57. doi: 10.1016/j.vaccine.2011.02.094. Epub 2011 Mar 17. Vaccine. 2011. PMID: 21419775

2

Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age.

Nassim C, Christensen S, Henry D, Holmes S, Hohenboken M, Kanesa-Thasan N. Nassim C, et al. Pediatr Infect Dis J. 2012 Apr;31(4):e59-65. doi: 10.1097/INF.0b013e31824b9545. Pediatr Infect Dis J. 2012. PMID: 22418661 Clinical Trial.

3

Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children.

Scheifele DW, Ward BJ, Dionne M, Vanderkooi O, Langley JM, Dobson S, Li Y, Law B, Halperin SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Rapid Trials Investigators. Scheifele DW, et al. Pediatr Infect Dis J. 2011 May;30(5):402-7. doi: 10.1097/INF.0b013e3182068f33. Pediatr Infect Dis J. 2011. PMID: 21178654

4

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

Roman F, Vaman T, Kafeja F, Hanon E, Van Damme P. Roman F, et al. Clin Infect Dis. 2010 Sep 15;51(6):668-77. doi: 10.1086/655830. Clin Infect Dis. 2010. PMID: 20687838 Clinical Trial.

5

Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults.

Palma P, Romiti ML, Bernardi S, Pontrelli G, Mora N, Santilli V, Tchidjou HK, Aquilani A, Cotugno N, Alghisi F, Lucidi V, Rossi P, Douagi I. Palma P, et al. Biologicals. 2012 Mar;40(2):134-9. doi: 10.1016/j.biologicals.2011.12.001. Epub 2012 Jan 20. Biologicals. 2012. PMID: 22261282 Clinical Trial.

6

Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals.

Kajaste-Rudnitski A, Galli L, Nozza S, Tambussi G, Di Pietro A, Pellicciotta G, Monti A, Mascagni P, Moro M, Vicenzi E. Kajaste-Rudnitski A, et al. AIDS. 2011 Jan 14;25(2):177-83. doi: 10.1097/QAD.0b013e328341afa8. AIDS. 2011. PMID: 21150561

7

Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.

Tremblay CL, Rouleau D, Fortin C, Toma E, Sylla M, Cyr L, Cote S, Baz M, Sampalis J, Trautman L, Sékaly RP, Boivin G. Tremblay CL, et al. Vaccine. 2011 Feb 4;29(7):1359-63. doi: 10.1016/j.vaccine.2010.12.023. Epub 2010 Dec 23. Vaccine. 2011. PMID: 21185423

8

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.

Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan DT, Podda A. Vesikari T, et al. Pediatr Infect Dis J. 2009 Jul;28(7):563-71. doi: 10.1097/INF.0b013e31819d6394. Pediatr Infect Dis J. 2009. PMID: 19561422 Clinical Trial.

9

Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.

Esposito S, Tagliaferri L, Daleno C, Valzano A, Picciolli I, Tel F, Prunotto G, Serra D, Galeone C, Plebani A, Principi N. Esposito S, et al. Vaccine. 2011 Feb 11;29(8):1677-82. doi: 10.1016/j.vaccine.2010.12.047. Epub 2011 Jan 1. Vaccine. 2011. PMID: 21199699 Clinical Trial.

10

Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.

Arguedas A, Soley C, Lindert K. Arguedas A, et al. N Engl J Med. 2010 Jan 28;362(4):370-2. doi: 10.1056/NEJMc0909988. Epub 2009 Dec 30. N Engl J Med. 2010. PMID: 20042746 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

189 results

Results by year